Hand sanitizer placement’s impact on psoriasis patient trust
Part of Skin clinical trials.
This study looks at whether where hand sanitizer is placed in the doctor's office affects how much patients trust their doctor and how they feel about the stigma of their skin condition. It may help improve the experience of people getting treatment for psoriasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have psoriasis and are getting care at the special psoriasis clinic.
- You can understand and fill out a questionnaire, either on your own or with help from family.
- You do not have severe vision, hearing, or speech problems that make talking with your doctor hard.
- You have no serious mental health condition that could affect how you answer questions.
- You are not at the visit for an emergency, like a bad skin infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at medical records from people with psoriasis to understand how the condition relates to other health problems like heart disease and joint issues. It may help researchers and doctors learn more about treating the whole person, not just the skin.
This study looks at how blood sugar control (including diabetes) changes immune cells in the skin for people with moderate to severe plaque psoriasis. It may help researchers understand what drives psoriasis and how it could respond to future treatments.
This study looks at how gum disease (periodontitis) may be linked to psoriasis. By examining your mouth, the researchers hope to learn more about the connection, which could help improve care for people with both conditions.
This observational study is looking at adults with skin psoriasis and collecting real-world information about their condition and experiences. It may help researchers better understand psoriasis and how it affects people, without giving a new treatment.
This trial tests a new study drug called HSK44459 for people with moderate to severe plaque psoriasis. The hope is that the drug can reduce psoriasis symptoms and improve quality of life. Participation involves receiving the study drug and being monitored for safety and effectiveness.
This study looks at the skin’s germs (“microbiome”) in people with atopic dermatitis (eczema) or psoriasis. It may help researchers better understand what’s going on on the skin and how that might relate to disease severity.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.